Related content

Compliance with osteoporosis drug therapy and risk of fracture

By Weycker D.   Macarios D.   Edelsberg J.   Oster G.  

Osteoporosis International, Vol. 18, Iss. 3, 2007-03 ,pp. : 271-277

Springer Publishing Company

Access to resources Recommend Favorite

Compliance with drug therapy for postmenopausal osteoporosis

By Weycker D.   Macarios D.   Edelsberg J.   Oster G.  

Osteoporosis International, Vol. 17, Iss. 11, 2006-11 ,pp. : 1645-1652

Springer Publishing Company

Access to resources Recommend Favorite

The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 12, 2015-12 ,pp. : 2411-2416

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA

By Dawson-Hughes B.   Tosteson A.   Melton L.   Baim S.   Favus M.   Khosla S.   Lindsay R.  

Osteoporosis International, Vol. 19, Iss. 4, 2008-04 ,pp. : 449-458

Springer Publishing Company

Access to resources Recommend Favorite

Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review

By Elliot-Gibson V.   Bogoch E.   Jamal S.   Beaton D.  

Osteoporosis International, Vol. 15, Iss. 10, 2004-10 ,pp. : 767-778

Springer Publishing Company

Access to resources Recommend Favorite